
Opinion: The decades-long journey to Gilead’s twice-a-year HIV prevention drug lenacapavir
On Thursday, the FDA approved lenacapavir, to be sold as Yeztugo, for the prevention of HIV in the U.S. The below essay, adapted from “Breakthrough: The Quest for Life-Changing Medicine” by William Pao, looks at lenacapavir’s decades-long journey to …